Biotech Co. Overstated Research Credit, Tax Court Says
A biotechnology company overstated its research credit for 2014 by improperly excluding clinical testing expenses, the U.S. Tax Court ruled Wednesday, upholding a notice of deficiency from the Internal Revenue Service....To view the full article, register now.
Already a subscriber? Click here to view full article